These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30694420)

  • 1. Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema.
    Weber LF; Marx S; Auffarth GU; Scheuerle AF; Tandogan T; Mayer C; Khoramnia R
    J Ophthalmic Inflamm Infect; 2019 Jan; 9(1):3. PubMed ID: 30694420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis.
    Hikal M; Celik N; Auffarth GU; Kessler LJ; Mayer CS; Khoramnia R
    J Clin Med; 2021 Sep; 10(17):. PubMed ID: 34501414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
    Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
    Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
    Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
    Studsgaard A; Clemmensen KØ; Nielsen MS
    Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN
    Panos GD; Arruti N; Patra S
    Eur J Ophthalmol; 2021 Mar; 31(2):620-629. PubMed ID: 31906704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.
    Singer MA; Sheth V; Mansour SE; Coughlin B; Gonzalez VH
    Ophthalmology; 2022 Jun; 129(6):605-613. PubMed ID: 35063472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN
    Carneiro A; Meireles A; Castro Sousa JP; Teixeira C
    Ther Adv Ophthalmol; 2020; 12():2515841420917768. PubMed ID: 32548568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes.
    Currie CJ; Holden SE; Berni E; Owens DR
    Curr Med Res Opin; 2017 Oct; 33(sup2):19-31. PubMed ID: 28881143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal fluocinolone acetonide implant for chronic postoperative cystoid macular edema - two years results.
    Chronopoulos A; Chronopoulos P; Hattenbach LO; Ashurov A; Schutz JS; Pfeiffer N; Korb C
    Eur J Ophthalmol; 2022 Sep; ():11206721221124688. PubMed ID: 36062617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME).
    McCluskey JD; Kaufman PL; Wynne K; Lewis G
    Int Med Case Rep J; 2019; 12():93-102. PubMed ID: 31114396
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 µg/d intravitreal implant: real-world UK experience.
    El-Ghrably I; Steel DHW; Habib M; Vaideanu-Collins D; Manvikar S; Hillier RJ
    Eur J Ophthalmol; 2017 May; 27(3):357-362. PubMed ID: 28165610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
    Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
    Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
    Jain N; Stinnett SS; Jaffe GJ
    Ophthalmology; 2012 Jan; 119(1):132-7. PubMed ID: 21924503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series.
    Schmit-Eilenberger VK
    Clin Ophthalmol; 2015; 9():801-11. PubMed ID: 25999689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.
    Shen BY; Punjabi OS; Lowder CY; Sears JE; Singh RP
    Retina; 2013 Apr; 33(4):873-7. PubMed ID: 23407350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.
    Lima-Fontes M; Leuzinger-Dias M; Barros-Pereira R; Fernandes V; Falcão M; Falcão-Reis F; Rocha-Sousa A; Alves-Faria P
    Ophthalmol Ther; 2023 Feb; 12(1):377-388. PubMed ID: 36417092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
    Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
    Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.